AURION BIOTECH, INC.
9Patents
9Active
9Granted
43Portfolio score
Filing activity: Aug 1, 2011 → Dec 23, 2020
Most-cited patents
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US8877808B2 | Protection against skin diseases by aurin tricarboxylic acid and its derivatives | Human Necessities | 1 | Active |
| US10398666B2 | Method for treating cancer with low molecular weight components of aurin tricarboxylic acid complex | Human Necessities | 0 | Active |
| US9751824B2 | Acetyl salicyclic acid dimers, synthesis thereof, and uses thereof to prevent and treat complement-mediated disorders | Emerging Cross-Sectional Technologies | 0 | Active |
| US10653651B2 | Kit for treating cancer with low molecular weight components of aurin tricarboxylic acid complex | Human Necessities | 0 | Active |
| US10588879B2 | Treatment of age-related macular degeneration | Emerging Cross-Sectional Technologies | 0 | Active |
| US10966945B2 | Selective inhibition of the membrane attack complex of complement by low molecular weight components of the aurin tricarboxylic synthetic complex | Human Necessities | 0 | Active |
| US12072334B2 | Corneal endothelial cell marker | Physics | 0 | Active |
| US10004707B2 | Method for treating cancer with low molecular weight components of aurin tricarboxylic acid complex | Human Necessities | 0 | Active |
| US11013750B2 | Methods for treating and preventing nociceptive pain | Human Necessities | 0 | Active |
Source: USPTO / EPO open patent data. Counts and citation impact are objective bibliographic measures.